A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer
about
A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Phase 3 Efficacy, Safety and ...... ophageal Junction (GEJ) Cancer
@en
type
label
A Phase 3 Efficacy, Safety and ...... ophageal Junction (GEJ) Cancer
@en
prefLabel
A Phase 3 Efficacy, Safety and ...... ophageal Junction (GEJ) Cancer
@en
P17
P6153
P1050
P1476
A Phase 3, Global, Multi-Cente ...... Junction (GEJ) Adenocarcinoma
@en
P17
P1813
Spotlight
@en
P3098
NCT03504397
P580
2018-06-21T00:00:00Z
P582
2021-02-01T00:00:00Z